Quest Diagnostics Incorporated
DGX Healthcare Diagnostics & Research
Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.
Follow DGX
Quest Diagnostics Incorporated (DGX) Operating cash flow
Quest Diagnostics Incorporated's operating cash flow for fiscal 2025 was $1.9B, up 41.4% from $1.3B in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.9B. Over the past ten years it has ranged from $821.0M (fiscal 2015) to $2.2B (fiscal 2021); the current reading is higher than 82% of that period. Quest Diagnostics Incorporated ranks 4th of 52 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.9B | 41.38% |
| FY2024 | $1.3B | 4.87% |
| FY2023 | $1.3B | (25.96%) |
| FY2022 | $1.7B | (23.06%) |
| FY2021 | $2.2B | 11.37% |
| FY2020 | $2.0B | 61.30% |
| FY2019 | $1.2B | 3.58% |
| FY2018 | $1.2B | 2.13% |
| FY2017 | $1.2B | 5.29% |
| FY2016 | $1.1B | 35.93% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $597.0M | 114.75% |
| Mar 2026 | $278.0M | (40.22%) |
| Dec 2025 | $465.0M | (17.41%) |
| Sep 2025 | $563.0M | 3.49% |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| DGX Quest Diagnostics Incorporated | $1.9B |
| LH Labcorp Holdings Inc. compare | $1.6B |
| IDXX IDEXX Laboratories, Inc. compare | $1.4B |
| ILMN Illumina, Inc. compare | $1.1B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| MEDP Medpace Holdings, Inc. compare | $752.7M |
| RVTY Revvity Inc. compare | $627.6M |
| WAT Waters Corporation compare | $549.6M |
| GH Guardant Health, Inc. compare | −$185.2M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on DGX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement